NCT01199614View on ClinicalTrials.gov

HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 26, 2017

Study Completion Date

June 26, 2017

Conditions
Hypoparathyroidism
Interventions
DRUG

open-label PTH(1-84)

open label PTH(1-84) at either 25mcg every other day, 25mcg every day, 50mcg daily, 75mcg daily, or 100mcg daily

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Collaborators (2)

NPS Pharma
Shire
All Listed Sponsors
collaborator

NPS Pharma

INDUSTRY

collaborator

Shire

INDUSTRY

lead

Columbia University

OTHER